Table of Contents
Executive Summary
Industry Introduction, including Taxonomy and Market Definition
Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
- By Drug Class
- By Route of Administration
- By Indication
- By Distribution Channel
By Drug Class
- Chemotherapy Drugs
- Alkylating Agents
- Antimetabolites
- Other Drugs
- Immunomodulating Drugs
- Targeted Therapy Drugs
- Proteasome Inhibitors
- Tyrosine Kinase Inhibitors
- mTOR Inhibitors
- Others
- Hormonal Therapy
By Route of Administration
- Oral
- Injectable
By Indication
- NSCLC
- Renal Cell Carcinoma
- Breast Cancer
- Prostate Cancer
- Multiple Myeloma
- Melanoma
- Lymphoma
- Leukemia
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Specialty Clinics
- Online Pharmacies
By Region
Sales Forecast to 2035 by Drug Class, Route of Administration, Indication, and Distribution Channel for 30 Countries
Competitive Assessment, Company Share Analysis by Key Players, and Competition Dashboard
Company Profile
- AstraZeneca
- 4SC AG
- Immunocure Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Gilead Sciences Inc.
- GlaxoSmithKline PLC
- Merck KGaA
- Hoffmann-La Roche Ltd
- Accent Therapeutics
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF